Effect of hepatic impairment on the pharmacokinetics (PK) of rosiglitazone (RSG)

• 1 February 1999
• journal article
• Published by Wiley in Clinical Pharmacology & Therapeutics
• Vol. 65  (2) , 186
• https://doi.org/10.1016/s0009-9236(99)80274-4

Abstract

Keywords

• ROSIGLITAZONE
• RSG
• EFFECT OF HEPATIC
• HEPATIC IMPAIRMENT ON THE PHARMACOKINETICS